Thuy Tran, MD, PhD

Link to our work highlighting the dual benefits of blocking MIF and PD-1 to treat cancer! Thank you to all of our collaborators and my mentor, @BucalaRichard! x.com/JCI_insight/st…

Overcoming resistance to immune checkpoint inhibitors remains a major objective in #cancer Here, Richard Bucala @BucalaRichard & team @YaleMed show combined anti-MIF and anti–PD-1 reduces tumor growth and improves survival in melanoma and colorectal cancer mouse models: insight.jci.org/articles/view/… The figure shows tumor regions of necrosis, immune infiltration, and reduced tumor volume in mice treated with MIF and PD-1.

Yale Develops Dual-Action Vaccine to Combat Aggressive Merkel Cell Carcinoma m.yale.edu/dcb9

.@TranMDPhD discusses a new #clinicaltrial using a customized #mRNA vaccine for patients with #melanoma and are at high risk for reoccurrence with @FOX61News. @SmilowCancer @SaintFrancisCT @YaleMed @YNHH fox61.com/article/news/h…

NEW: Episode 2 of our 6-part #Healthcast #podcast series on 50 years of the #NationaCancerAct of 1971. Dr. Jim Doroshow and Dr. Meg Mooney provide insight on 50 years of #CancerResearch diagnosis and treatment bit.ly/3vqLch5 #NothingWillStopUs #healthnews @GCIOMedia

Congrats to Dr. Sarah Weiss, MD, on her latest authorship demonstrating T cell infiltration differences in paired, melanoma brain compared to extracranial metastases. Check out our publication here: pubmed.ncbi.nlm.nih.gov/32974852/

Excited to share our findings using #realworlddata showing the approval of #immunotherapy and patterns of care at end of life @flatironhealth @cpgYALE @DrBlytheAdamson @Ron_cology @ravi_b_parikh @CPresGeriOncMD @YaleCOPPER @PennCancer @StanfordCancer ascopubs.org/doi/abs/10.120…

Sharing an important message from the dedicated staff at #YaleNewHavenHospital. We should all be doing our part to help curb the spread of COVID-19 and protect those in our community who are most at risk. Medicine is a team effort!

Thank you @OtisBrawley for visiting Yale today @YaleCancer @SmilowCancer @YaleMedicine as our Paul Calabresi Professor and spending time meeting with fellows/trainees. Great learning about your career focus and efforts to combat disparities in cancer care to promote prevention!

A fun way to conclude #VailWorkshop19 with PDG10 and Dr. Von Hoff!

Happy to be part of the fantastic PDG 10 this year at #VailWorkshop19! I think we ended this week with everyone's protocol much improved and hope to keep in touch with all of these great trainees as they grow in their careers!

Writing clinical protocols ✅ Meeting inspirational Faculty ✅ Hiking beautiful mountains ✅ Making awesome friends ✅ Dreaming Big ✅ #VailWorkshop2019 was absolutely Spectacular 👌🏼

So happy to share my work, published this week in #jitc, which evaluated the effect of immunotherapy on tumor-associated edema in individuals with brain metastasis. Here’s to the wonderful patients and their amazing altruism for making research possible! rdcu.be/bMHKR

Learning from a master @DrRoyHerbstYale at giving scientific presentations (but with a great sense of humor) #VailWorkshop19!

Finally peer pressured into joining Twitter. My awesome roomie @YAbdouMD is teaching me so much beyond the #VailWorkshop19 clinical trial protocols. Working hard to develop promising trials to improve patient care but making great friends in the process!